Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Harriet Walter

Has grant

Associate Professor of Medical Oncology

University Hospitals of Leicester NHS Trust

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cell Biology Cell Biology professors in United Kingdom

Recent Grants

Grant: Open

A Phase 2 Open Label Trial of Sonrotoclax in Combination With Zanubrutinib in Patients With Relapsed/Refractory Hairy Cell Leukaemia

Open Date: 2026-01-01

Close Date: 2030-01-01

Grant: Close

Establishment of a Rare B Cell Malignancies Database

Open Date: 2025-01-01

Close Date:

Grant: Close

Innovate UK Knowledge Transfer Award

Open Date: 2024-01-01

Close Date:

Grant: Open

Leicester ECMC

Open Date: 2023-01-01

Close Date: 2028-01-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (26)

Jordi Esteve Reyner

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

SPAIN

View details

Stephen Tait

Professor of Mitochondrial Cancer Biology

University of Glasgow

UNITED KINGDOM

View details

Carmelo Carlo‐Stella

IRCCS Humanitas Research Hospital

ITALY

View details

Jenny O'Nions

UNITED KINGDOM

View details

Claire Hutchinson

Senior Clinical Lecturer

University of Plymouth

UNITED KINGDOM

View details

Yufang Shi

Distinguished Professor

University of Rome Tor Vergata

ITALY

View details

Philip Knuckles

Friedrich Miescher Institute for Biomedical Research

SWITZERLAND

View details

Martin Dyer

Professor

University of Leicester

UNITED KINGDOM

View details

Ana Alfonso-Piérola

MD, PhD

Clinica Universidad de Navarra

SPAIN

View details

Victoria M Smith

University of Southampton

UNITED KINGDOM

View details

Carlo M. Croce

Distinguished University Professor

Ohio State University

UNITED STATES

View details

Debashis Sarker

King’s College London

UNITED KINGDOM

View details

David Allsup

Professor

Hull York Medical School

UNITED KINGDOM

View details

Gerry Melino

ITALY

View details

Andrew D Beggs

University of Birmingham

UNITED KINGDOM

View details

Andreas Villunger

Medical University of Innsbruck

AUSTRIA

View details

Fay Cafferty

Principal Statistician

University College London

UNITED KINGDOM

View details

Richard Phillips

Speciality Training Registrar - ST3 to ST6

Queen Elizabeth Hospital Birmingham

UNITED KINGDOM

View details

Emmanuel GYAN

Professor of Hematology

Université de Tours Faculté de Médecine

FRANCE

View details

Manish Pareek

Head of Division

University of Leicester

UNITED KINGDOM

View details

Austin G Kulasekararaj

King's College Hospital NHS Foundation Trust

UNITED KINGDOM

View details

Martin Hutchings

Professor

University of Copenhagen

DENMARK

View details

Darren Hargrave

University College London

UNITED KINGDOM

View details

Roch Houot

university hospital of Rennes

FRANCE

View details

Magdalena Meissner

Clinical Senior Lecturer

Cardiff University

UNITED KINGDOM

View details

Rebecca Baggaley

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Harriet Walter

Research Interests

Explore related searches

Recent Grants

Articles (20)

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology

Acalabrutinib monotherapy as a first-line treatment for CLL: 3-year follow-up of the real-world EPIC study.

What does BCL-2 do? From new molecular insights to the clinical implications

Mapping the barriers and facilitators of oral healthcare access for vulnerable migrants across high-income countries: a scoping review

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up

BI-1808+pembrolizumab: Responses to a chemotherapy-free regimen in advanced ovarian cancer.

Decentralised Oncology Trials in the UK: Evidence, Regulation and Academic Clinical Trials Units' Perspectives

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Updated design of INVOKE: A phase 1 study of OKN4395, a first-in-class EP2/EP4/DP1 triple prostanoid receptor antagonist, in patients with advanced solid tumors

In vitro comparison of CD20xCD3 bispecific antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20

A phase 1, first‐in‐human, dose‐escalation study of JNJ‐74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS

A call for action: closing the gap on ethnic disparities in oral cavity cancer care

Distinct mechanisms of CD28 and 4-1BB costimulation in glofitamab combination therapies for relapsed/refractory non-Hodgkin lymphoma (R/R NHL)

Evaluation of Clinical Parameters Associated with Response and Resistance to Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma: A Multi-Institutional Retrospective Cohort Study

INVOKE: A phase 1 study of OKN4395, a first-in-class EP2/EP4/DP1 triple prostanoid receptor antagonist, in patients with advanced solid tumors.

TP53 aberrant Mantle Cell Lymphoma treated with first-line systemic therapy: A real-world analysis of outcomes in 120 patients treated in the United Kingdom

The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusion

Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma

19-BI-1808-01, a phase 1/2a clinical trial of BI-1808, a tumor necrosis factor receptor 2 (TNFR2) blocker/depleter with or without pembrolizumab.

A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma

Collaborators (26)

Jordi Esteve Reyner

Stephen Tait

Carmelo Carlo‐Stella

Jenny O'Nions

Claire Hutchinson

Yufang Shi

Philip Knuckles

Martin Dyer

Ana Alfonso-Piérola

Victoria M Smith

Carlo M. Croce

Debashis Sarker

David Allsup

Gerry Melino

Andrew D Beggs

Andreas Villunger

Fay Cafferty

Richard Phillips

Emmanuel GYAN

Manish Pareek

Austin G Kulasekararaj

Martin Hutchings

Darren Hargrave

Roch Houot

Magdalena Meissner

Rebecca Baggaley

Make your next move.